Gulf International Bank (UK)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Gulf International Bank (UK)’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,283	Closed	-$636K	–	659
2024 Q1	$636K	Hold	5,283	–	–	0.02%	574
2023 Q4	$649K	Sell	5,283 -590	-10%	-$73.6K	0.02%	569
2023 Q3	$760K	Sell	5,873 -496	-8%	-$66.1K	0.02%	551
2023 Q2	$789K	Sell	6,369 -1,897	-23%	-$255K	0.02%	567
2023 Q1	$1.21M	Sell	8,266 -268	-3%	-$39.6K	0.03%	525
2022 Q4	$1.36M	Hold	8,534	–	–	0.02%	541
2022 Q3	$1.14M	Hold	8,534	–	–	0.02%	550
2022 Q2	$1.33M	Hold	8,534	–	–	0.02%	538
2022 Q1	$1.33M	Hold	8,534	–	–	0.02%	560
2021 Q4	$1.09M	Sell	8,534 -1,572	-16%	-$207K	0.02%	595
2021 Q3	$1.31M	Hold	10,106	–	–	0.02%	607
2021 Q2	$1.79M	Hold	10,106	–	–	0.02%	581
2021 Q1	$1.66M	Sell	10,106 -1,500	-13%	-$247K	0.02%	574
2020 Q4	$1.92M	Buy	+11,606	New	+$1.73M	0.03%	559

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Gulf International Bank (UK)'s JAZZ Position: Q2 2024 in Review

Gulf International Bank (UK) sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 5,283 shares — an estimated $636K sold.

Gulf International Bank (UK) first reported a position in JAZZ in Q4 2020 and held it in 14 quarters. The position peaked at $1.92M in Q4 2020. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

Gulf International Bank (UK) reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Gulf International Bank (UK) sold 5,283 Jazz Pharmaceuticals shares in Q2 2024, an estimated $636K.
Gulf International Bank (UK) first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 14 quarters.
Gulf International Bank (UK)'s Jazz Pharmaceuticals position peaked at $1.92M in Q4 2020.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Gulf International Bank (UK)'s 13F filing for Q2 2024, filed 10 Jul 2024.